Edwards Lifesciences Corporation (EW)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:30AM EDT. Market open.
| Previous close | 86.96 |
| Open | 87.40 |
| Bid | 87.33 x 1100 |
| Ask | 87.42 x 800 |
| Day's range | 86.76 - 87.79 |
| 52-week range | 60.57 - 96.12 |
| Volume | |
| Avg. volume | 4,034,369 |
| Market cap | 52.819B |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | 38.15 |
| EPS (TTM) | 2.30 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 94.52 |
ZacksIs a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
ZacksUnveiling Edwards Lifesciences (EW) Q1 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Simply Wall St.A Look At The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Edwards Lifesciences fair value estimate is US$76.62 With...
© 2024 Yahoo. All rights reserved.